EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Effect of Statin Therapy following Endovascular Treatment of Intracranial Aneurysms: A Meta-Analysis

Mingguo Li, Yuan Yao, Jian Liu, Yuanguang Pang, Qian Wu, Cong Liu

Cerebrovascular Diseases · 2025

DOI: 10.1159/000547504 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Cerebrovascular Diseases, 2025. Verfasst von Mingguo Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First People's Hospital of Neijiang, Neijiang, China, limingg168@sina.com. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Endovascular Procedures, Intracranial Aneurysm. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Endovascular treatment has become one of the standard therapies for intracranial aneurysms (IAs), yet the prognosis remains a persistent clinical challenge. This study aimed to systematically evaluate the efficacy and safety of adjuvant statin therapy following endovascular treatment (EVT) of IAs.

Methods

A systematic review and meta-analysis were conducted in accordance with the PRISMA guidelines. Cohort studies comparing outcomes between patients with IAs who received statin therapy following EVT and those who did not were included. Efficacy outcomes included retreatment, recurrence, and complete occlusion, whereas safety outcomes included ischemic stroke, intracerebral hemorrhage (ICH), thrombosis, and all-cause mortality. A random-effects model was applied, and subgroup and sensitivity analyses were performed on the basis of treatment modality and adjustment for confounding factors.

Results

Six retrospective studies comprising 3,692 patients were analyzed. Sensitivity analysis revealed that statin therapy significantly reduced the risk of retreatment (adjusted odds ratio [aOR] 0.35, 95% CI: 0.15–0.81) and recurrence (aOR 0.29, 95% CI: 0.12–0.65), whereas no significant difference was found in complete occlusion rates (aOR 0.94, 95% CI: 0.52–1.71). Although the unadjusted risk of ischemic stroke was greater in the statin group, this association was not significant after adjustment (aOR 1.04, 95% CI: 0.30–3.60). No significant differences were observed in other safety outcomes, including ICH, thrombosis, or all-cause mortality.

Conclusion

Statins may help reduce the risk of recurrence and retreatment of IAs following EVT, suggesting their potential adjunctive role in the management of IAs and providing a rationale for conducting prospective investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsEndovascular ProceduresIntracranial AneurysmHumansTreatment OutcomeRisk FactorsRecurrenceMaleMiddle AgedFemaleAgedRisk AssessmentOdds RatioTime Factors

Stichwörter der Autor:innen

Endovascular treatmentIntracranial aneurysmMeta-analysisStatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Neurosurgery, The First People's Hospital of Neijiang, Neijiang, China, limingg168@sina.com.
  • Department of Anesthesiology, The First People's Hospital of Neijiang, Neijiang, China.
  • Department of Neurosurgery, The First People's Hospital of Neijiang, Neijiang, China.

Zitieren

APA

Li, M., Yao, Y., Liu, J., Pang, Y., Wu, Q., & Liu, C. (2025). Effect of Statin Therapy following Endovascular Treatment of Intracranial Aneurysms: A Meta-Analysis. Cerebrovascular Diseases. https://doi.org/10.1159/000547504

Vancouver

Li M, Yao Y, Liu J, Pang Y, Wu Q, Liu C. Effect of Statin Therapy following Endovascular Treatment of Intracranial Aneurysms: A Meta-Analysis. Cerebrovascular Diseases. 2025. doi:10.1159/000547504

BibTeX
@article{Li2025,
  author = {Li, Mingguo and Yao, Yuan and Liu, Jian and Pang, Yuanguang and Wu, Qian and Liu, Cong},
  title = {Effect of Statin Therapy following Endovascular Treatment of Intracranial Aneurysms: A Meta-Analysis},
  journal = {Cerebrovascular Diseases},
  year = {2025},
  doi = {10.1159/000547504}
}
Kostenlos starten →